Next generation sequencing (NGS) is the method of choice for simultaneous genomic profiling of multiple biomarkers. Researchers use rhAmpSeqTM and xGenTM targeted sequencing systems to amplify highly multiplexed targets. This combination offers flexible, high-quality solutions for targeted sequencing, accelerating human disease research.
Download this application note from Integrated DNA Technologies to learn how researchers use combined NGS approaches to identify and confirm biomarkers in cancer samples.
For research use only. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.